Transplantation of Human Tumours into Mouse-brain by Lumb, G.
434
TRANSPLANTATION OF HUMAN TUMOURS
INTO MOUSE-BRAIN.
G. LUMB.
From the Imperial Cancer Research Fund Laboratories at the Royal College of Surgeons,
London, and the Department of Pathology, Westminster Medical School, London.
Received for publication July 22, i954.
THE maintenance of human tumours under artificial conditions is a problem
which has tested experimental workers for many years. Heterologous trans-
plantation into different animals has been considered by most observers as unlikely
to succeed for a variety of reasons, among which may be quoted the essential
specificity ofthe protein make-up ofcells in any particular animal species and the
immune reaction leading to their destruction which is likely to be set up on
their introduction into a heterologous strain. Failure of growth in new surroun-
dings is characterised by lymphocytic infiltrations, proliferations of fibroblasts,
collagen formation and failure of vascularisation. Loeb (1930) felt that death
of a transplant within a few days of inoculation was due to immune responses
by connective tissue elements at the site rather than secondary development of
humoral antibodies. Sites for inoculation were sought where blood supply and
connective tissue capable of immediate granulomatous response against a foreign
body were minimal and where it might be hoped that foreign cells would become
established sufficiently in their new environment to withstand vascularisation
and subsequently to gain nourishment from it in order to proliferate.
As early as 1873 Van Dooremaal suggested that the anterior chamber of the
eye might provide a suitable site for inoculation and in 1884 Zahn attempted to
transplant a human chondroma inthisway. Itbecameinfiltrated bylymphocytes
and was absorbed.
Subsequent experiments seemed to confirm the early fears offailure and most
workers formed the view that whilst homologous transplantation-that is trans-
ference into a like species-was sometimes possible, particularly when a rapidly
growing tumour was employed, heterologous transplantation would prove uni-
formly unsuccessful.
In 1937 Smirnova reported successful transference of a human mammary
carcinoma, and Greene with co-workers, in a series of papers from 1938 up to the
present time, has described successful results of heterologous transplantation of
human tumours, usually into the anterior chamber of the eyes of guinea pigs,
although other animals such as rabbits have been used.
The results obtained by Greene have been more successful than those reported
by other workers and he has developed the thesis that the ability of tumours to
survive in heterologous species may be a measure of the ability of the malignant
cell to metastasise. He recognises two groups of tumours from the point of view
oftransplantability, the difference between which is not based on the morphology
of the neoplasm, but on the results of their behaviour in the patient. Thus he
describes two groups of tumours, one of which contains hetero-transplantable
material obtained from patients whose disease follows a rapidly fatal course,TRANSPLANTATION OF HUMAN TUMOURS
and the other consists of material from patients who live for considerable periods
of time. He goes further to suggest that when a tumour becomes capable of
metastasis it also becomes possible to transplant it successfully into heterologous
species. (Greene, 1952).
This view is supported by Lemon and Parsons (1952) who base their opinion
on a small series of cases; but Towbin (1951a) reporting on the results of one
hundred different human tumours, and thirty-eight different animal tumour trans-
plants,wasunabletoconfirmthesefindings tohissatisfaction and concludedthatre-
lativelyfewhumantumours, eventhough clinicallymalignant, can betransplanted
successfully to the anterior chamber of the guinea pig's eye. He felt that this
factor precludes the use ofthe technique as a practical measure for differentiating
benign from malignant tumours. Morris, McDonald and Mann (1950) agree with
these conclusions. After attempting to transplant forty different human malig-
nant tumours they decided that successful heterotransplants into the anterior
chamber of the eye can "seldom be accomplished." It was their view, however,
that more successful results could be obtained if the tumour was introduced
into the lens.
Although the anterior chamber of the eye has been the most popular site for
attempted heterotransplantation, many other anatomical areas have been used,
most of which have proved unsuccessful, with the exception of the brain in mice
and the cheek pouch in hamsters. Greene (1951) has reported successes with
mouse-brain inoculation and Lemon and Parsons (1952) have reported early
successes in the hamster cheek pouch.
In addition to the search for a suitable site for tumour transplantation various
attempts have been made to assist growth in the new surroundings. Most of
these attempts have been designed to counteract or inhibit the immune reaction
on the part of the host. Pre-operative irradiation of the host animal in order to
reduce circulating lymphocytes has been tried by Toolan (1951) with apparent
improvement in the transplanted tumour growth. Cortisone and A.C.T.H.
have been administered but so far few reports of results are available. Several
workers, among whom may be mentioned Toolan (1951), Lemon and Parsons
(1952), and Dobyns and Lennon (1952), have tried serial transplantation ofhuman
tumours, and the last named authors describe a single case ofa thyroid carcinoma
which they have maintained by serial transplantation over a period of 31 years.
In addition they record the interesting fact ofan increasing degree ofhistological
differentiation in the tumour during this period.
It has been suggested that the criteria for assessing continued viability of a
tumour in its new surroundings are not sufficiently accurate and that the demon-
stration of cells which are alive as judged by histological means, or an increase
in total size ofa tumour, does not necessarily indicate a "take." Towbin (1915b)
has pointed out in relation to transplantation to guinea pig anterior chamber that
gross appearances may be deceptive and must be substantiated by histological
studies. He has suggested the analysis oftransplantation results in three stages.
1. A stage of suspension which may be compared to the conditions of tissue
culture where the aqueous humour acts as a temporary nutritional medium.
2. A stage of nidation where the transplanted tumour elements become inte-
grated with the vascular system ofthe new host. At this stage death may occur,
or if the transplantation is successful, growth will ensue. In many cases Towbin
(1951b) considers that a period of growth arrest may develop where no change
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takes place in the tumour transplant and this stage may be maintained for very
long periods.
3. A stage of growth when, if transplantation has been completely successful,
the tumour proliferates.
The use of mammalian or avian brain as a focus for the transplantation of
heteroplastic tissue seems to have been recorded first by Shirai in 1921 who
reported briefly that tumours from rats had been grown successfully in the brains
of chickens, pigeons and other animals. Murphy in 1926 presented a careful
account of the transplantation of mouse sarcoma and carcinoma into rat brain.
He recorded satisfactory and rapid growth up to periods of 3 to 4 weeks.
It was his opinion that failure of growth of a heteroplastic graft was not due
to any lack ofsuitable nutrient material or to the formation ofspecific antibodies.
The evidence available was, hefelt, that the cellularreaction was ofthe firstimpor-
tance in determining the fate of a heteroplastic graft. The accumulation of
small round cells around foreign material introduced into the higher animals has
been well recorded, and it was Murphy's (1926) view that where this reaction is
absent as in the embryo or in the brain, the heteroplastic graft meets with no
resistance and its rate of growth is at least as great as it would be in the native
host. He felt that all his evidence pointed to the importance of the lymphoid
type of cell in the resistance to foreign tissue, and he performed experiments of
reducing total lymphocytes by X-irradiation and by adding lymphocytic material,
usually in the form of fresh spleen, along with the implanted tissue, the results
of which he felt confirmed his theory.
In view ofthe relatively small number ofreports in the literature ofthe results
of heterotransplantation of human tumours it was decided to commence a series
of experiments. A start has been made using the mouse-brain for inoculation
as this site appeared to have beenthe least studied, but later the anterior chamber
in guinea pigs has been used and more recently still, experiments have been
commenced in which the cheek-pouch of the hamster has been utilised. This
presentation is a report of the results obtained following transplantation of sixty
different human tumours into mouse-brain and the account will be confined
largely to changestaking place during the first 4 to 5 weeks followinginoculation.
TECHNIQUE.
Malignant human tumours are obtained from Westminster Hospital. The
portion for inoculation is selected under aseptic conditions in or near the operating
theatre immediately afterremoval. An attempt is made to take a piece oftumour
with as little stroma as possible and also to avoid obvious areas of necrosis or
haemorrhage. The specimen is placed in a sterile container and transported
at once to the laboratories of the Imperial Cancer Research Fund at the Royal
College of Surgeons of England. The time interval at best is in the region of 20
minutes, but delays up to an hour are sometimes unavoidable. Speed of trans-
ference is ofvital importance in this operation andfor this reason a series ofexperi-
ments are to be performed where inoculation is done on the spot and the animals
subsequently transferred to the laboratory. So far no attempt has been made to
maintain the tumour at any particular temperature during the interval between
its removal and its inoculation.
The animals used are mice ofup to 10 weeks ofage. In the light ofthe experi-
ence ofprevious workers, young animals are preferred, but in view ofthe irregular
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availability of human tumour material it has been found impossible to insist on
any very particular age. In the early stages of the experiment pure bred C3H
mice were used, but later mixed strains have been accepted with no apparent
effect on results.
Basal anaesthesia is employed (0.1 c.c. ofa0.016 per cent solution ofnembutal
per 10 g. weight of mouse) and is administered intraperitoneally. This gives
quite rapid deep anaesthesia which lasts for 2 hours. It has the distinct advantage
that a batch ofmice can be prepared when the human operation is about to com-
mence so that the experimental animals are ready for inoculation as soon as the
tumour is available, thus cutting down the transference time interval.
The method of inoculation is to shave the skin of the mouse's head over the
vertex and to make a small incision down to the bone. In the earlier experiments
a small triangular bone flap was then raised which could be replaced at the end of
the operation. This has been found unnecessarily complicated and time con-
suming, so that now a small hole is made with the end of a corneal scalpel. The
skull ofthe mouse is thin yet rigid so that little difficulty is experienced in applying
the correct pressure to produce a hole without damaging the underlying brain.
Bleeding is usually minimal and can be stopped quickly by gentle pressure with
a gauze swab.
A small fragment of tumour is then introduced into the brain either on the
end of a blunted hypodermic needle, or, after rough mincing with scissors, it can
be drawn into the needle and either pushed in with the needle stylette or forced
in by pressure from an ordinary syringe. A No. 18 gauge hypodermic needle
preferably provided with a guard at 3 mm. from its blunted point, has been
found the most useful instrument for this procedure. Two points of importance
emerge in connection with the technique of tumour introduction. Firstly,
only a very tiny fragment of tumour material should be used. Larger pieces
tend to undergo rapid necrosis. It is clearly impossible to define an exact size
but the inoculum either minced or unminced should represent a piece of tumour
certainly not more than 1 mm. in diameter. The second point of importance
is to make sure that when the needle is removed from inside the skull, the tumour
inoculum does not also come out. No great difficulty is experienced in achieving
this, but a small practical point of importance is to make the line of needle entry
oblique to the skull hole.
When inoculation is complete the skin is drawn together over the wound and
sealed with collodion. The mouse is then replaced in its cage and within 12-18
hours returns to apparent complete normality. Mortality among the mice as a
result of the operation is related directly to operation technique. In the earlier
part ofthe experiment 20 mice were inoculated in each batch and 2 or 3 fatalities
within the first 3 days were common. Now 10 mice are inoculated in each batch
and a fatality is a matter of extreme rarity.
A portion of the tumour inoculated is fixed and examined histologically.
When experiments were commenced an attempt was made to select a suitably
cellular area of tumour by performing immediate frozen sections. No apparent
advantage resulted from this, and it had the disadvantage of causing delay in
inoculation so that it has now been abandoned.
The whole procedure of inoculation is performed using aseptic precautions.
The operation takes place in a sterile chamber and sterile rubber gloves are worn
by the operator. Until fully recovered from the anaesthetic mice are segregated,
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but after 24 hours, inoculated batches are kept together under normal animal
house conditions.
RESULTS.
Throughout the experiment close observation of the inoculated mice has been
maintained in order to observe any signs of cerebral compression resulting from
tumour growth in the skull. No such signs appeared and it was early decided to
kill the mice after specific intervals in order to examine the brains. The times
selected for observation were at first 10, 15 and 21 days, but later when it was
realised that in the absence of complete failure something would be seen in most
cases at 10 days, the times were changed to 15, 21 and 28 days. More recently
still, mice are killed at 15, 28 and 35 days. This report will be confined to obser-
vations made at these times, but from each batch some mice are sacrificed for
serial transplantation experiments whilst others are kept indefinitely.
In the early stages of the experiment when technique had not been fully
developed each tumour specimen was inoculated into 20 mice, but in order to
economise in storage space 10 mice have been used since the time when operative
mortality became negligible. Two mice are killed on each selected day and the
remainder ofthe batch used for other purposes orkeptindefinitely. The common-
est cause of an operative death is haemorrhage into the brain substance. When
the animal is killed the head is removed and a post-mortem performed on the
remainder of the body. No example of metastasis from inoculated tumours has
been discovered.
The skin is carefully stripped from the skull and although even by 10 days
considerable or complete healing at the site of inoculation is found, it is usually
quite easy to see where the tumour has been put into the skull up to several weeks
afterwards. Next the bone is removed and the brain carefully extracted intact.
Again it is usual to be able to see macroscopically the point of inoculation on the
surface ofthe cerebrum. The cerebellum and pons are removed and in some cases
where the tumour is obvious the cerebellum is trimmed towards the site. The
remaining specimen is then fixed routinely for 24 hours in Formol-acetic (Suza's
fixative as modified byHeidenhein). This fixative is found suitable as it preserves
good cytological detail and at the same time tends to make the brain firm and so
facilitates subsequent section cutting. Serial sections are then cut from each
specimen although it is usual for the section cutter to be able to recognise the point
in the block where he begins to cut through the tumour area. Every fifth section
has been retained and ofthese, alternate ones are stained routinely by haematoxy-
]in and eosin, leaving the intervening sections for further investigation ifrequired.
The tumours which have been used up to date are listed in Table 1 and are
seen to be made up of sixty different human cases which fall into the following
groups:
Cases.
Carcinoma of breast . . . . 27
Squamous cell carcinomas . . 8
Melanomas . . . . . 6
Ovarian carcinomas . . . . 6
Carcinomas ofgastro-intestinal tract . 8
Sarcomas . . . . . . 3
Carcinoma oflung . . . . 1
Carcinoma ofkidney . . . . 1
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TABLE I.
No. Age. Sex. Tumour type.
1 . 55 . F . Carcinoma breast
.. ..
.. .
.. ..
.. ..
.. .
.. ..
.. ..
.. .
.. ..
.. .
.. a mu cel.ar
..noma
.. .
..tto
.. .
.. .
.. . ..lanom
Car
Car(
Car
Oste
Oste
Ca
Car(
Metastases
present or absent
(+ or-).
+ but pre-op irr.
+ Glands in axilla
+ , .. ..
+ Glands in axilla
*
+ Glands in axilla
* +I- ,. ,,..... .
+ Glands in axilla
* -I-~~~~~~~~.
+ ,. . ..
+ ,. ...
+ Rec. ca.penis.
· + Glands from tongue.
· +Glands from larynx.
* + Glands from tongue.
. + Glands c ervixuteri.
· -Skin carcinoma
· ± Glands from tongue.
* +I ,. .. .
*
,, . + Glands from groin
,, . + ,, in ,,,,*~~~~~~~+,..
cinoma ovary . + Omental spread
...., . + Generalised
,,. , . + Krukenberg
...., . + Generalised ...,.. + Omental spread
...., . + Liver
,, stomach . + Adjacent glands
+ Glands
cinoma rectum . + ,,
,, ,, * + ,,
,, ~~~ ,, * ,,
rcinoma colon . + Adjacent glands
pi, ,, + ,. .
ogenic sarcoma .
Fibrosarcoma
)ogenic sarcoma
rcinoma lung
cinoma
kidney
Tissue
used for
inoculation.
Primary tumour
Metastasis
Primary tumour
Metastasis
Primary tumour.
Metastasis
Primary tumour
Metastasis
Primary tumour
Metasta-sis
,. ..~~~~Meatai..
,. a tai ..
Mea. a i ..Meatai..
. Primary tumour .
Metastasis
· Primary tumour
· Metastasis
. Primary tumour .
.. ..~
.. .
Met tsi
. .. .~~~~~~~~
.·rmr tmu
.. ..-
·. .
.. ..
43
66
67
62
45
48
43
69
45
59
65
62
54
62
47
55
57
49
72
47
43
52
45
45
57
61
49
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
M
M
M
M
F
M
M
M
F
M
F
F
F
M
F
F
F
F
F
F
M
F
F
F
M
M
M
F
M
M
M
M
M
No. of
days up to
which definite
cells seen in
mouse-brain.
Failure
364 days
28 ,,
15 ,,
Failure
21 days
15 ,,
Failure
15 days
Failure
21 days
Failure
21 days
21 ,,
28 ,,
28 ,,
Failure
21 days
35 ,,
28 ,,
28 ,,
Failure
28 days
Failure
28 days
21 ,,
21 ,,
21 ,,
21 ,,
15 ,,
21 ,,
21 ,,
Failure
21 days
28 ,,
28 ,,
28 ,,
Failure
15 days
15 ,
28 ,,
15 ,,
21 ,,
21 ,,
Failure
,,(inf.)
35 days
21 ,,
21 ,,
28 ,,
Failure
28 days
15 ,,
Failure (inf.)
35 days
56
48
66
51
42
64
52
31
61
52
63
57
58
31
37
61
50
49
40
64
73
73
63
61
62
62
49
22
79
23
54
56
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They are arranged in the table to show the age, sex and diagnosis of the patient
fromwhom the tumour was taken, in addition to the result achieved on transplan-
tation expressed in terms of number of days after inoculation at which tumour
cells could be recognised by histological means.
In those cases where tumour cells are found they reproduce closely the histo-
logical appearances they presented when growing in human tissues and are readily
recognisable (Fig. 6-15). The site ofinoculationinthe brainis clear cut and shows
a sharp line of demarcation between inoculum and normal brain. The resulting
growths following implantation tend to produce a discrete rounded nodule (Fig.
1) pushing aside the surrounding brain rather than infiltrating it. At 10 and 15
day periods necrosis of some of the tumour cells is seen. Sometimes maximum
cell death is central in a nodule (Fig. 2) and more rarely it is the peripheral cells
of a tumour clump which are mainly affected (Fig. 3). This death of cells is
frequently associated with aninfiltration ofpolymorphonuclearleucocytes (Fig. 3).
In brains examined at 21 days where some tumour cells have survived, inflam-
matory cellular infiltration is minimal both in the tumour nodule itself and also
about its edges. Small vessels inthevicinityhowever, tend to be dilatedandshow
perivascular "cuffing" by small round cells of lymphocyte type (Fig. 4). Fre-
quently small vessels are seen plugged with lymphocytes. At 28 and 35 day
periods in most of the cases examined in this series histologically identifiable
EXPLANATION OF PLATES.
FIG. 1.-Discrete rounded nodule of tumour well demarcated from surrounding brain. Trans-
plant from metastasis from carcinoma ovary after 15 days. H. & E. X 55.
FIG. 2.-Central necrosis in group of cells from a fibrosarcoma after 15 days. H. & E. x 110.
FIG. 3.-Peripheral death ofcells with well marked polymorphonuclear leucocyte proliferation
from a squamous cell carcinoma 10 days after transplantation. H. & E. X 100.
FIG. 4.-Lymphocytic infiltration around small vessels at edge of inoculation area. H. & E.
x 250.
FIG. 5.-Zone of inoculation where malignant cells have disappeared. Vascularisation and
early fibrosis have taken place. H. & E. x 120.
FIG. 6a.-Carcinoma of breast, Stage II before inoculation. H. & E. x 260.
FIG. 6b.-Inoculated tumour in Fig. 6a after 21 days. H. & E. x 260.
FIG. 7a.-Carcinoma of breast, Stage II before inoculation. H. & E. x 250.
FIG. 7b.-Inoculated tumour in Fig. 7a after 15 days. H. & E. x 350.
FIG. 8a.-Carcinoma of breast, Stage II before inoculation. H. & E. x 240.
FIG. 8b.-Inoculated tumour in Fig. 8a after 21 days. H. & E. x 280.
FIG. 9a.-Metastasis in gland from squamous cell carcinoma before inoculation. H. & E.
X 260.
FIG. 9b.-Inoculated tumour in Fig. 9a after 21 days. H. & E. x 80.
FIG. 9c.-Inoculated tumour in Fig. 9a after 21 days showing mitotic figure. H. & E. x 650.
FIG. lOa.-Metastasis in gland from melanoma before inoculation. H. & E. x 280.
FIG. lOb.-Inoculated tumour in Fig. lOa after 29 days. H. & E. x 280.
FIG. lla.-Metastasis in gland from melanoma before inoculation. H. & E. x 280.
FIG. llb.-Inoculated tumour in Fig. 1la after 21 days. H. & E. x 280.
FIG. llc.-Inoculated tumour in Fig. 1la after 15 days invading ventricle. H. & E. x 280.
FIG. 12a.-Metastasis in ovary (Krukenberg) before inoculation. H. & E. x 280.
FIG. 12b.-Inoculated tumour in Fig. 12a after 15 days. Note mitotic figures. H. & E.
x 280.
FIG. 13a.-Peritoneal metastasis from carcinoma of ovary before inoculation. H. & E.
x 320.
FIG. 13b.-Inoculated tumour from Fig. 13a after 10 days. H. & E. x 320.
FIG. 14a.-Peritoneal metastasis from carcinoma of stomach before inoculation. H. & E.
x 280.
FIG. 14b.-Inoculated tumour from Fig. 14a after 21 days. H. & E. x 280.
FIG. 15a.-Fibrosarcoma before inoculation. H. & E. x 280.
FIG. 15b.-Inoculated tumour in Fig. 15a after 10 days. H. & E. x 120.
FIG. 16.-Squamous cell carcinoma proliferating over surface of ventricle 21 days after inoculation
H.& E. X350.
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tumour cells have disappeared but when they are present they appear as clumps
of cells unassociated with any cellular infiltration.
At the 21 and 28 day period vascularisation ofthe inoculation zone is the most
striking feature. Small capillary blood vessels are seen in abundance and in the
areas where tumour cells have disappeared fibroblast proliferation occurs (Fig. 5).
Lymphocytic infiltration is not a marked feature of the cerebral inoculations and
is restricted to the periphery of the tumour zone. This is in marked contra-
distinction to the appearances in the anterior chamber of guinea-pig or rabbit
eye. In those cases where all tumour cells have been removed, a small focus of
fibrous tissue is left from which all vessels gradually disappear leaving a small
zone oforganised collagen.
The clearly demarcated inoculation site in the brain is always very much
larger than the tiny fragment of tumour tissue which is introduced. This zone
is not always completely occupied by tumour cells and on many occasions the
apparently large size of the site is the result of swelling by tissue fluid.
Certain special features have emerged in relation to specific tumours when
introduced into the brain. In the case of breast carcinomas the tissue remaining
in the transplantation area when the brains are examined tends to show clumps of
well differentiated duct and acinar elements (Fig. 6b, 7b and 8b). At first sight
some of these give the appearance of normal duct tissue, but so far no example
of normal tissue surviving in the brain has been demonstrable. The explanation
would appear to be either that the best differentiated areas survive or that in the
new surroundings the ceils tend to arrange themselves in patterns which are
apparently well differentiated.
Breast tumours are probably the commonest malignant tumour available for
transplantation purposes in that they usually occur free from bacterial contamina-
tion. They are unfortunately however, not the best suited tumours for this
purpose as they tend to occur in their commonest form in close association with
fibrous tissue. Twenty-seven have been used in this series and in 16 cases clumps
oftumour cells have been foundwiththe appearances described above. Squamous
cell carcinomas have reproduced their normal histological appearances very
closely in the mouse brain, producing easily recognisable "cell nests" (Fig. 9b)
showing mitotic figures around the periphery of the cell clumps (Fig. 9c).
Malignant melanomas have also produced encouraging results where solid
clumps of apparently viable cells with occasional mitoses have been found (Fig.
10b and 1lb) and in one case evidence of what appears to be infiltration into the
ventricle is seen (Fig. 1lc).
Difficulty has been experienced so far with tumours of the gastro-intestinal
tract because of bacterial contamination. Two cases of carcinoma of the rectum
produced abscesses in the brain on inoculation. In 2 cases of carcinoma of the
colon and a case of carcinoma of the stomach metastases were used with some
success (Fig. 14a, and 14b).
Murphy (1926) in reporting his results of transplantation into mouse-brain
stressed the fact that when tumours came in contact with the ventricle, rapid
death resulted and he recommended that care should be taken to avoid inocula-
tions near these structures. This has not been the experience in these experiments,
for in a number of cases foci of tumour cells have been found in close association
with the ventricles and in the case mentioned above, a melanoma appears to be
directly infiltrating into a small narrowing of one (Fig. 11c). One squamous
30
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cell carcinoma spread over the surface of the ventricle (Fig. 16) giving the impres-
sion that in this particular tumour the ventricular surface provided a particularly
suitable medium for tumour cell proliferation.
The results which have been described so far are in relation to normal mice, but
twenty of the human tumours were inoculated both into untreated mice and into
mice previously treated by a single whole body dose of 500 r delivered by a 22(0
Kv. generator. This dose was found by a series of experiments to lower the peri-
pheral leucocyte count from an average of 8,000-9,000 per cu. mmn. to 400-50(0
per cu. mm. With this dose it was decided that a maximal fall of circulating
leiicocytes could be achieved compatible with absence of untoward effects in the
mice. The purpose of treating the mice with pre-operative X-irradiation was to
investigate whether or not a diminution of circulating leucocytes would affect
transplantation results. Many authors, among whom Murphy (1926) in particular
may be quoted, have suggested the importance of the role of the lymphocyte in
heterologous transplantation.
The results obtained in this experiment showed no striking variations from those
which were achieved in non-irradiated mice. It was decided that any difference
did not merit a continuation of the experiment as it had been designed, for the
following reason.
The maximum fall of circulating leucocytes occurs 48-60 hours after treatment
and remains at the low level for about 7-10 days, when, ifthe mouse is unaffecte(ld,
the level rises to normal again. It has been stated already that unlike the anterior
chamber of the eye the lymnphocytic response in the brain is minimal in the early
stages after transplantation, and therefore it would seem likely that at the 3-4
week period when a depressed number of lymphocytes might be an advantage,
very little effect would be gained from irradiation. It is felt that irradiation
after the tumour has been inoculated would clearly be disadvantageous as it
would tend to affect the transplanted tumour cells. For these reasons, therefore,
irradiation has been discontinued except in those cases where serial transplantation
is being studied.
DISCUSSION.
In reporting results so far, care has been taken simply to record presence or
absence of histologically recognisable tumour tissue without making any attempt
to interpret results in terms of "takes." Many authors, including Snell (1954)
and Towbin (1951a, 1951lb), have stressed the confusion which arises by recording
results simply in terms of "take" or "failure" without making clear the state-
ment. It is obvious that if a transplanted tumour grew as a solid mass to destroy
a considerable area of host tissue then no doubt would remain that frank growth
was taking place in the transplanted area. The most striking evidence of success
of transplantation would be metastasis within the new host, an occurrence which
seems unlikely to happen and which has not been claimed even by workers whose
results have been most successful.
So far in these experiments no example of metastasis or massive growth has
been seen. Only occasionally are mitoses demonstrable and only in 2 cases has
there been evidence of infiltration by tumour cells at the edge of the inoculation
area. The appearances in "successful" cases have been of isolated areas at the
transplantation sites sharply demarcated from adjacent brain showing clumps of
cells which by the normal methods of histology appear to be viable. If it were
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claimed that these cells represent simply a process of suspended animation some-
where between living and dying, but incapable oftrue proliferation in the manner
of a tumour, then very little argument could be brought to the contrary. In
the assessment of results so far, however, when careful consideration has been
taken ofthe amount ofapparently viable tumour material remaining demonstrable
in the period up to 5 weeks after inoculation, the opinion has been formed that the
most anaplastic tumours and in particular frank metastases from tumours produce
the most active results (Table II).
TABLE II.
Type oftumour.
Carcinoma of breast
Squamous cell carci-
noma
Melanoma
Carcinoma of ovary
Carcinoma of stomach .
Carcinoma of rectum
Carcinoma of colon
Carcinoma of lung
Carcinoma of kidney
Sarcomas
No. cases
inoculated.
27
No. cases with
cells demon-
strable in
mouse-brain.
16
8
6
6
4
5
2
3
3
1
1
3
1
1
No. of
failures. Notes.
11 . 8 failures were turn-
ours which had not
metastasised. 12
successes had al-
ready metastasised.
1 . Six ofthe eight cases
were metastases.
2 . The two failures
were primary. The
four successes were
metastases.
1 . Four of the five
successes were
metastases. The
failure was a prim-
1
2
3
1~~~~~~ 1
2 . 1
ary.
· Both failures were
infected primaries.
Success was a meta-
stasis.
. All cases had meta-
stasised.
. This was a very ana-
plastic primary
tumour.
. The two successes
were primaries.
It has already been stated that Greene has claimed that heterologous trans-
plantation results can be used as an assessment of the virulence of the human
tumour in terms of the patient's progress and prognosis. No such immediate
claim can be made as a result of these early experiments, but on the other hand
it is felt that sufficient promise exists to make worth while a more extensive
series of inoculations when the following facts must be established. In the first
place it must be made certain whether all normal and benign material fails to
survive a transplantation as our early findings and those ofother workers suggest.
Next, further malignant tumours must be studied in order to establish whether
the apparent truth that the degree of malignancy as expressed by behaviour on
transplantation can be substantiated.
If the apparent constancy of these results over a relatively small group of
cases can be confirmed in large series, then the appearances seen in the trans-
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plantation area could conceivably be used in the assessment of a biological test
of degree of malignancy, irrespective of whether they represent the true power
ofgrowth proliferation or only of suspended animation or nidation.
SUMMARY.
1. A report is given of the results obtained following heterologous transplan-
tation of sixty different human tumours into mouse-brain.
2. The histological appearances during the first 28 to 35 days after inoculation
are described.
3. The merits ofpre-operative irradiation of the mice are discussed.
4. The tentative suggestion is made that better results are obtained with more
rapidly growing and metastasing tumours.
5. Necessity for rapidity of transfer from host to experimental animal is
stressed.
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